Expert Teaches on Hepatocellular Carcinoma. Today hepatocellular carcinoma still remains one of the most deadly types of cancer. To discuss Hepatocellular carcinoma in more detail, we’ve invited one of Ohio State University’s experts. Dr. Lanla Conteh is an Associate Professor of Medicine, specializing in Transplant Hepatology. She directs the Hepatobiliary Tumor Program at OSU, and if that weren’t enough, she also researches Hepatocellular Carcinoma and disparities in patients with liver disease. On this webcast, she will be reviewing the epidemiology, treatment and prevention strategies for Hepatocellular Carcinoma.
What you’ll learn in this webcast
As a result of this educational activity, webcast participants will be able to:
- Recognize the increasing incidence of liver cancer
- Recognize the importance of screening and introduce different treatment options available
You’ll also learn about the following:
- Causes of Hepatocellular Carcinoma
- Screening for Liver Disease
- Treating Hepatitis B
- Referral
You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.